Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials

被引:423
作者
Gadient, RA
Otten, UH
机构
[1] VESALIANUM, DEPT PHYSIOL, CH-4051 BASEL, SWITZERLAND
[2] CALTECH, DIV BIOL, PASADENA, CA 91125 USA
关键词
D O I
10.1016/S0301-0082(97)00021-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-6 (IL-6), a member of the neuropoietic cytokine family, initially was described in terms of its activities in the immune system and during inflammation. Accumulating evidence supports an essential role of IL-6 in the development, differentiation, regeneration and degeneration of neurons in the peripheral and central nervous system. Major sites of IL-6 synthesis are neurons and glial cells. Interleukin-6 functions are mediated by a specific receptor system composed of a binding site and a signal transducer. This receptor system can be modulated by a complex of IL-6 and soluble IL-6 receptor acting as agonist. The IL-6 can exert completely opposite actions on neurons, triggering either neuronal survival after injury or causing neuronal degeneration and cell death in disorders such as Alzheimer's disease. Development of selective IL-6 agonists and antagonists, as well as the usage of soluble IL-6 receptors. offers new possibilities for the treatment of neurodegenerative disorders. Furthermore, optimized genetic mouse models, including transgenic and knockout animals, should help to define the physiological and pathophysiological role of IL-6 in the nervous system. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 134 条
  • [1] HUMAN ACOUSTIC NEUROMAS SECRETE INTERLEUKIN-6 IN CELL-CULTURE - POSSIBLE AUTOCRINE REGULATION OF CELL-PROLIFERATION
    ADAMS, EF
    RAFFERTY, B
    MOWER, J
    WARD, H
    PETERSEN, B
    FAHLBUSCH, R
    [J]. NEUROSURGERY, 1994, 35 (03) : 434 - 438
  • [2] INTERLEUKIN-1-BETA ENHANCES SURVIVAL AND INTERLEUKIN-6 PROTECTS AGAINST MPP(+) NEUROTOXICITY IN CULTURES OF FETAL-RAT DOPAMINERGIC-NEURONS
    AKANEYA, Y
    TAKAHASHI, M
    HATANAKA, H
    [J]. EXPERIMENTAL NEUROLOGY, 1995, 136 (01) : 44 - 52
  • [3] PENETRATION OF INTERLEUKIN-6 ACROSS THE MURINE BLOOD-BRAIN-BARRIER
    BANKS, WA
    KASTIN, AJ
    GUTIERREZ, EG
    [J]. NEUROSCIENCE LETTERS, 1994, 179 (1-2) : 53 - 56
  • [4] INTERLEUKIN-6 AND ALPHA-2-MACROGLOBULIN INDICATE AN ACUTE-PHASE STATE IN ALZHEIMERS-DISEASE CORTICES
    BAUER, J
    STRAUSS, S
    SCHREITERGASSER, U
    GANTER, U
    SCHLEGEL, P
    WITT, I
    YOLK, B
    BERGER, M
    [J]. FEBS LETTERS, 1991, 285 (01) : 111 - 114
  • [5] INDUCTION AND REGULATION OF INTERLEUKIN-6 GENE-EXPRESSION IN RAT ASTROCYTES
    BENVENISTE, EN
    SPARACIO, SM
    NORRIS, JG
    GRENETT, HE
    FULLER, GM
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1990, 30 (2-3) : 201 - 212
  • [6] Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    BlumDegen, D
    Muller, T
    Kuhn, W
    Gerlach, M
    Przuntek, H
    Riederer, P
    [J]. NEUROSCIENCE LETTERS, 1995, 202 (1-2) : 17 - 20
  • [7] BOLIN LM, 1995, J NEUROCHEM, V64, P850
  • [8] Bourde O, 1996, J NEUROIMMUNOL, V69, P135
  • [9] BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86
  • [10] DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS
    BREITNER, JCS
    WELSH, KA
    HELMS, MJ
    GASKELL, PC
    GAU, BA
    ROSES, AD
    PERICAKVANCE, MA
    SAUNDERS, AM
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (04) : 523 - 530